LEX Diagnostics Ltd

LEX Diagnostics Limited (now acquired by QuidelOrtho) is a molecular diagnostics company specializing in ultra-fast point-of-care PCR testing platforms. Based in Melbourn, United Kingdom, the company develops the LEX VELO system, a CLIA-waived compact PCR molecular diagnostics platform designed for decentralized healthcare settings including physician offices, urgent care centers, pharmacies, and hospitals. The LEX VELO system delivers lab-quality results with minimal hands-on time (less than one minute), reporting positive results in as little as six minutes and negative results in under ten minutes. The current test menu includes multiplex detection and differentiation of Influenza A, Influenza B, and COVID-19, with planned expansion to include Strep A, RSV, and STIs. The system features a fully automated swab-to-result workflow with no swab elution or liquid sample handling required, significantly reducing infection risk and operational complexity in point-of-care settings.